Constitutively active adenosine monophosphate-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes

Circulation

Volumn 107, Issue 15, 2003, Pages 1962-1965

  Light, Peter E ^a   Wallace, Catriona H R ^a   Dyck, Jason R B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenosine monophosphate; AMP activated protein kinase; Arrhythmia; Ion channels; Protein kinases

Indexed keywords

ADENOSINE PHOSPHATE; ADENOVIRUS VECTOR; PROTEIN KINASE; SODIUM CHANNEL; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SUBSTRATE; ENZYME SUBUNIT; FATALITY; GENE MUTATION; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART VENTRICLE; HYPERPOLARIZATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM CURRENT; ACTION POTENTIAL; AMINO ACID SUBSTITUTION; ANIMAL; CELL CULTURE; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY;

ACTION POTENTIALS; AMINO ACID SUBSTITUTION; ANIMALS; ARRHYTHMIA; CELLS, CULTURED; ENZYME ACTIVATION; HEART VENTRICLES; HUMANS; MULTIENZYME COMPLEXES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; RATS; RECOMBINANT PROTEINS; SODIUM CHANNELS; TRANSFECTION;

EID: 0037461107     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000069269.60167.02     Document Type: Article

References (22)

1. Hardie DG, Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem. 1997;246:259-273.
2. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999;277(1 pt 1):E1-E10.
3. Cheung PC, Salt IP, Davies SP, et al. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J. 2000;346(pt 3):659-669.
4. Lang T, Yu L, Tu Q, et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5′-AMP-activated protein kinase, to human chromosome 7q36. Genomics. 2000;70:258-263.
5. Dyck JR, Gao G, Widmer J, et al. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem. 1996;271:17798-17803.
6. Kudo N, Barr AJ, Barr RL, et al. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem. 1995;270:17513-17520.
7. Hallows KR, McCane JE, Kemp BE, et al. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J Biol Chem. 2003;278:998-1004.
8. Gollob MH, Seger JJ, Gollob TN, et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. 2001;104:3030-3033.
9. Hamilton SR, Stapleton D, O'Donnell JB, Jr, et al. An activating mutation in the gammal subunit of the AMP-activated protein kinase. FEBS Lett. 2001;500:163-168.
10. Gollob MH, Green MS, Tang AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 2001;344:1823-1831.
11. Gollob MH, Green MS, Tang AS, et al. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr Opin Cardiol. 2002;17:229-234.
12. Bennett PB, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
13. Grant AO. Molecular biology of sodium channels and their role in cardiac arrhythmias. Am J Med. 2001;110:296-305.
14. + channels in diabetic rat hearts. Am J Physiol. 1998;275(4 pt 1):E568-E576.
15. Stein SC, Woods A, Jones NA, et al. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J. 2000;345(pt 3):437-443.
16. Light PE, Bladen C, Winkfein RJ, et al. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci U S A. 2000;97:9058-9063.
17. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev. 1999;79:917-1017.
18. Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med. 2002;112:58-66.
19. Ju YK, Saint DA, Gage PW. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol. 1996;497(pt 2):337-347.
20. Benhorin J, Taub R, Goldmit M, et al. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation. 2000;101:1698-1706.
21. Daniel T, Carling D. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White Syndrome. J Biol Chem. 2002;277:51017-51024.
22. Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice overexpressing mutant PRKAG2 recapitulate the human cardiomyopathy, characterized by ventricular hypertrophy and preexcitation. Circulation. 2002;106:705.